Abstract
The short synthetic interfering RNA duplexes (siRNAs) can selectively suppress gene expression in somatic mammalian cells without nonselective toxic effects of double-stranded RNA (dsRNA). However, a selective in vivo delivery of siRNA transfer has not been reported in kidney. Here, we investigated whether injection of synthetic siRNAs via renal artery followed by electroporation could be effective and therapeutic in silencing specific gene in glomerulus. We investigated the effect of siRNA in rat cultured mesangial cells (MCs) and showed that siRNA sequence-specific suppression of transgene expression was over a 1000-fold more potent than that by antisense oligodeoxynucleotide (ASODN). Transfection of siRNA targeting luciferase into rat kidneys significantly inhibited expression of a cotransfected luciferase expression vector in vivo. The delivery of siRNA targeting enhanced green fluorescent protein (EGFP) in the transgenic ‘green’ rat reduced endogenous EGFP expression, mainly in glomerular MCs. Furthermore, RNAi targeting against TGF-β1 significantly suppressed TGF-β1 mRNA and protein expression, thereby ameliorated the progression of matrix expansion in experimental glomerulonephritis. In addition, vector-based RNAi also inhibited TGF-β1 expression in vitro and in vivo. In conclusion, siRNA-directed TGF-β1 silencing may be of therapeutic value in the prevention and treatment of fibrotic diseases.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Fire A et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998; 391: 806–811.
Hannon GJ . RNA interference. Nature 2002; 418: 244–251.
Billy E et al. Specific interference with gene expression induced by long, double-stranded RNA in mouse embryonal teratocarcinoma cell lines. Proc Natl Acad Sci USA 2001; 98: 14428–14433.
Elbashir SM et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001; 411: 494–498.
Tsujie M et al. Electroporation-mediated gene transfer that targets glomeruli. J Am Soc Nephrol 2001; 12: 949–954.
Border W, Noble N . Transforming growth factor in tissue fibrosis. N Engl J Med 1994; 331: 1286–1292.
Noah DL, Blum MA, Sherry B . Transfection of primary cardiac myocyte cultures with DNA and anti-sense oligonucleotides using FuGENE 6 transfection reagent. Biochemica 1998; 2: 38–40.
Ito T et al. Bone marrow is a reservoir of repopulating mesangial cells during glomerular remodeling. J Am Soc Nephrol 2001; 12: 2625–2635.
McCaffrey AP et al. RNA interference in adult mice. Nature 2002; 418: 38–39.
Song E et al. RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med 2003; 9: 347–351.
Xia H, Mao Q, Paulson HL, Davidson BL . siRNA-mediated gene silencing in vitro and in vivo. Nat Biotechnol 2002; 20: 1006–1010.
Valdes VJ, Sampieri A, Sepulveda J, Vaca L . Using double-stranded RNA to prevent in vitro and in vivo viral infections by recombinant baculovirus. J Biol Chem 2003; 278: 19317–19324.
Border WA et al. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1. Nature 1990; 346: 371–374.
Bridge AJ et al. Induction of an interferon response by RNAi vectors in mammalian cells. Nat Genet 2003; 34: 263–264.
Sledz CA et al. Activation of the interferon system by short-interfering RNAs. Nat Cell Biol 2003; 5: 834–839.
Kennedy S, Wang D, Ruvkun G . A conserved siRNA-degrading RNase negatively regulates RNA interference in C. elegans. Nature 2004; 427: 645–649.
Sugiura T et al. Group II phospholipase A2 activates mitogen-activated protein kinase in cultured rat mesangial cells. FEBS Lett 1995; 370: 141–145.
Kawachi H et al. Epitope-specific induction of mesangial lesions with proteinuria by a MoAb against mesangial cell surface antigen. Clin Exp Immunol 1992; 88: 399–404.
Novina CD et al. siRNA-directed inhibition of HIV-1 infection. Nat Med 2002; 8: 681–686.
Akagi Y et al. Inhibition of TGF-beta1 expression by antisense oligonucleotides suppressed extracellular matrix accumulation in experimental glomerulonephritis. Kidney Int 1996; 50: 148–155.
Nakamura H et al. Introduction of DNA enzyme for Egr-1 into tubulointerstitial fibroblasts by electroporation reduced interstitial alpha-smooth muscle actin expression and fibrosis in unilateral ureteral obstruction (UUO) rats. Gene Therapy 2002; 9: 495–502.
Daniel C et al. Antisense oligonucleotides against thrombospondin-1 inhibit activation of TGF-beta in fibrotic renal disease in the rat in vivo. Am J Pathol 2003; 163: 1185–1192.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Takabatake, Y., Isaka, Y., Mizui, M. et al. Exploring RNA interference as a therapeutic strategy for renal disease. Gene Ther 12, 965–973 (2005). https://doi.org/10.1038/sj.gt.3302480
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3302480
Keywords
This article is cited by
-
Increased glomerular filtration rate and impaired contractile function of mesangial cells in TRPC6 knockout mice
Scientific Reports (2017)
-
Kidney-specific Sonoporation-mediated Gene Transfer
Molecular Therapy (2016)
-
Fighting against kidney diseases with small interfering RNA: opportunities and challenges
Journal of Translational Medicine (2015)
-
siRNA Technology in Kidney Transplantation: Current Status and Future Potential
BioDrugs (2014)
-
Towards microRNA-based therapeutics for diabetic nephropathy
Diabetologia (2013)